| Structure |
Chemical Name |
CAS |
MF |
 |
Etoricoxib N'-Oxide |
325855-71-8 |
C18H15ClN2O3S |
 |
Oseltamivir |
651324-07-1 |
C26H44N2O4 |
 |
Flucloxacillin Impurity 2 |
|
|
 |
Cefminox Impurity 4 |
|
|
 |
Adefovir Impurity 4 |
|
|
 |
Febuxostat Impurity 69 |
|
|
 |
Furosemide Impurity 16 |
133989-65-8 |
C12H12N2O6S |
 |
Linagliptin Impurity 53 |
|
|
 |
Nintedanib Impurity 52 |
2410284-89-6 |
C22H30N6O2 |
 |
Olaparib Impurity 21 |
|
|
 |
Oseltamivir Impurity 43 |
|
|
 |
Rosuvastatin Impurity 48 |
|
|
 |
Sildenafil Impurity 37 |
|
C22H30N6O4S |
 |
Sitagliptin Impurity 80 |
|
|
 |
Teneligliptin Impurity 2 |
|
|
 |
Ticagrelor Impurity 104 |
|
|
 |
Ticagrelor Impurity 95 |
|
|
 |
Tofacitinib Impurity 120 |
|
|
 |
2-(2-Fluoro-4-iodo-aniline)-4-hydroxy-1, 5-dimethyl-6-oxo-1,6-dihydro-pyridine-3-carboxylic acid cyclopropylamide |
3018911-27-5 |
C17H17FIN3O3 |
 |
Pramipexole EP Impurity E |
106006-84-2 |
C10H15N3OS |
 |
3-Morpholinone, 4-phenyl- |
29518-11-4 |
C10H11NO2 |
 |
H 128/80 |
29122-74-5 |
C13H19NO3 |
 |
4’-Hydroxy Atomoxetine -D-Glucuronide |
540729-08-6 |
C23H29NO8 |
 |
Vildagliptin Impurity 46 |
|
|
 |
Carbocistein Impurity C |
|
|
 |
(2S,4R)-N-((2S,3S,4S)-1-(((2S,3R)-5-amino-1 |
|
|
 |
Erythromycin Impurity 4 |
|
|
 |
Itraconazole iMpurity 5 |
|
|
 |
Trelagliptin Impurity 15 |
|
|
 |
Sofosbuvir Impurity 57 |
|
|
 |
Celecoxib Impurity 6 |
|
C17H14F3N3O2S |
 |
Emtricitabine Impurity 6 |
|
|
 |
Erlotinib Impurity 26 |
|
|
 |
Fosaprepitant Impurity 5 |
|
|
 |
Dapoxetine Impurity 5 |
1181810-25-2 |
C19H16O |
 |
Regorafenib Impurity 10 |
|
|
 |
Bosutinib Impurity 7 |
|
|
 |
Ticagrelor Impurity 12 |
|
|
 |
Ticagrelor Impurity 63 |
2227766-79-0 |
C9H9ClFN |
 |
Canagliflozin Impurity 5 |
|
|
 |
Canagliflozin Impurity 15 |
2803375-40-6 |
C30H32O5S2 |
 |
Oseltamivir Impurity 31 |
|
|
 |
Riociguat IMpurtiy C |
|
|
 |
Aclidinium Bromide Impurity 1 |
|
|
 |
Ampicillin Impurity 7 |
|
|
 |
Meropenem impurity diastereomer 1 |
96035-27-7 |
C15H19N3O5S |
 |
methyl 4-hydroxy-6-phenoxyisoquinoline-3-carboxylate |
1509958-11-5 |
C17H13NO4 |
 |
Palbociclib-012 |
2206135-30-8 |
C41H55N11O5 |
![(3S,4S)-3-(β-D-Glucopyranosyloxy)dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone](/CAS/20211123/GIF/858127-38-5.gif) |
(3S,4S)-3-(β-D-Glucopyranosyloxy)dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone |
858127-38-5 |
C26H32O12 |
 |
Tigecycline Impurity E |
|
|
 |
Cefminox Impurity B |
|
|
 |
isopropyl 4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl) benzenesulfonate |
|
C20H19F3N2O3S |
 |
N-(2-HYDROXYETHYL)ISONICOTINAMIDE, 99 |
6265-74-3 |
C8H10N2O2 |
 |
BENAZEPRIL RELATED COMPOUND G (15 MG) ((3-(1 -ETHOXYCARBONYL-3-PHENYL-(1 S)-PROPYL)AMINO-2,3,4,5-TETRAHYDRO-2-OXO-1H-1-(3S)-BENZAZE-PINE)-1-ACETIC ACID, ETHYL ESTER) |
103129-58-4 |
C26H32N2O5 |
 |
MILRINONE RELATED COMPOUND A (50 MG) (1,6-DIHYDRO-2-METHYL-6-OXO(3,4'-BIPYRIDINE)-5-CAR-BOXAMIDE) |
80047-24-1 |
C12H11N3O2 |
 |
PREDNICARBATE IMPURITY F |
|
|
![2-Propanol, 1,1'-[methylenebis(4,1-phenyleneoxy)]bis[3-[(1-methylethyl)amino]-](/CAS/20200515/GIF/1225195-70-9.gif) |
2-Propanol, 1,1'-[methylenebis(4,1-phenyleneoxy)]bis[3-[(1-methylethyl)amino]- |
1225195-70-9 |
C25H38N2O4 |
 |
Telmisartan impurities1039 |
2031272-32-7 |
C47H40N4O4 |
![(4R,5S,6S)-3-[[(3S,5S)-1-[(4-Aminophenyl)methyl]-5-[[(3-carboxyphenyl)amino]carbonyl]-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid Sodium Salt](/CAS/20210111/GIF/866186-66-5.gif) |
(4R,5S,6S)-3-[[(3S,5S)-1-[(4-Aminophenyl)methyl]-5-[[(3-carboxyphenyl)amino]carbonyl]-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid Sodium Salt |
866186-66-5 |
C29H33N4NaO7S |
 |
(R)-cis-5ξ-Methyl Atracurium Dibesylate |
1193104-82-3 |
C60H79N2O15S+ |
 |
2-(((Z)-(1-(2-Aminothiazol-4-yl)-2-(((2R,3R)-2-methyl-4-oxo-1-sulfoazetidin-3-yl)amino)-2-oxoethylidene)amino)oxy)-2-methylpropanoic Acid |
|
C13H17N5O8S2 |
![7-[4-[2-[[[4-(3-Carboxy-6-fluoro-1-methyl-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinolin-7-yl)-1-piperazinyl]carbonyl]oxy]-3-oxobutyl]-1-piperazinyl]-6-fluoro-1-methyl-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid](/CAS/20210111/GIF/156834-58-1.gif) |
7-[4-[2-[[[4-(3-Carboxy-6-fluoro-1-methyl-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinolin-7-yl)-1-piperazinyl]carbonyl]oxy]-3-oxobutyl]-1-piperazinyl]-6-fluoro-1-methyl-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid |
156834-58-1 |
C37H36F2N6O9S2 |
 |
(6R,7S)-7-ACCA |
108260-07-7 |
C7H7ClN2O3S |
 |
Enrofloxacin Impurity 1 |
1128234-60-5 |
C19H22ClN3O3 |
 |
Peramivir Impurity 20 |
|
|
 |
Ambroxol Impurity 33 |
199472-91-8 |
C13H20N2O |
 |
Bilastine Impurity 12 |
1638785-18-8 |
C30H42N4O3 |
 |
Tadalafil Impurity 66 |
1598416-07-9 |
C21H18N2O5 |
 |
Peramivir Impurity 36 |
|
|
 |
4-CHLORO-7-(2-CHLORO-ETHOXY)-6-(2-METHOXY-ETHOXY)-QUINAZOLINE |
183322-20-5 |
C13H14Cl2N2O3 |
 |
METHYL 2-(O-NITROBENZYLIDENE)-ACETOACETATE |
39562-27-1 |
C12H11NO5 |
 |
Sugammadex sodium Impurity 48 |
|
|
 |
Sugammadex sodium Impurity 47 |
|
|
 |
Tenofovir Impurity 95 |
1884329-63-8 |
C8H10BrN5 |
 |
Tenofovir Impurity 117 |
1643116-22-6 |
C8H11N5O |
![3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile](/CAS/20211123/GIF/2374700-40-8.gif) |
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile |
2374700-40-8 |
C16H20N6O |
![7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-2-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)- (9CI)](/CAS/20210305/GIF/129815-82-3.gif) |
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-2-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)- (9CI) |
129815-82-3 |
C18H20FN3O4 |
![Piperazine, 1-[2-[(4-methoxyphenyl)methyl]-4-methylphenyl]-](/CAS/20210305/GIF/769083-63-8.gif) |
Piperazine, 1-[2-[(4-methoxyphenyl)methyl]-4-methylphenyl]- |
769083-63-8 |
C19H24N2O |
 |
1,3-diisopropylurea |
4128-37-4 |
C7H16N2O |
![Acetic acid, 2-[(5-bromo-2-pyridinyl)amino]-2-oxo-, ethyl ester](/CAS/20210305/GIF/141354-54-3.gif) |
Acetic acid, 2-[(5-bromo-2-pyridinyl)amino]-2-oxo-, ethyl ester |
141354-54-3 |
C9H9BrN2O3 |
 |
Desacetylvinblastine hydrazide |
55383-37-4 |
C43H56N6O7 |
 |
4-hydroxypyrrolidin-2-one |
96820-00-7 |
C4H7NO2 |
 |
glycopyrronium bromide |
475468-09-8 |
C19H28NO3.Br |
![Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)imino]-3,4,5,6,7,8-hexahydro-8-hydroxy-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-](/CAS/20210305/GIF/1383430-03-2.gif) |
Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)imino]-3,4,5,6,7,8-hexahydro-8-hydroxy-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]- |
1383430-03-2 |
C26H23FIN5O5 |
 |
4'-hydroxyflurbiprofen |
52807-12-2 |
C15H13FO3 |
 |
D-biotin-d-sulfoxide |
10406-89-0 |
C10H16N2O4S |
 |
3,4-dihydroxyphenylpyruvic acid |
4228-66-4 |
C9H8O5 |
 |
delta(3)-cefotiam |
142182-63-6 |
C18H23N9O4S3 |
 |
alpha-(chloromethyl)-2-hydroxymethyl-5-nitroimidazole-1-ethanol |
62580-79-4 |
C7H10ClN3O4 |
 |
(3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-yl acetate |
2875066-46-7 |
C16H17F5O4 |
![(1R,2S)-2-[[(2,4-Dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-2-pyridinylcyclopropanecarboxamide](/CAS/20210305/GIF/1369763-94-9.gif) |
(1R,2S)-2-[[(2,4-Dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-2-pyridinylcyclopropanecarboxamide |
1369763-94-9 |
C22H21FN4O2 |
 |
Nemonoxacin Impurity 5 |
2770004-79-8 |
C24H29N3O8 |
 |
4-hydroxypenicillin V |
20880-67-5 |
C16H18N2O6S |
 |
BENAZEPRILAT |
86541-78-8 |
C22H24N2O5 |
 |
9-Methylene-9H-fluorene |
4425-82-5 |
C14H10 |
 |
2-PIPERIDIN-4-YL-1H-BENZOIMIDAZOLE |
38385-95-4 |
C12H15N3 |
 |
4-CHLORO-3,5-DIMETHYL 2-CHLORMETHYL PYRIDINE.HCL |
142885-96-9 |
C8H9Cl2N |
 |
9-DIHYDROESTRADIOL |
791-69-5 |
C18H22O2 |
 |
Decarboxy Ciprofloxacin |
105394-83-0 |
C16H18FN3O |
 |
Zolpidem 6-Carboxylic Acid |
109461-15-6 |
C19H19N3O3 |